Scientists have developed essentially new way of asthma and allergy treatment
The British scientists have moved closer to creation of essentially new class of of asthma and allergy drugs. They have found a target for medicinal substances, influence on which will allow to prevent development of symptoms, informs The Journal of Immunology.
Scientists from Barts and The London School of Medicine and Dentistry carried out the researches in vitro and on mice.
Asthma and various kinds of allergies are met very frequently. Only in Great Britain more than 30 % of inhabitants have this or that variety of an allergy, and about five millions people suffer from asthma. The majority of drugs are directed on symptoms removal, in particular, an itch of eyes or coryza. There are also some epistatic immunity drugs; however these preparations increase susceptibility of an organism to infections.
The medicines blocking p110-delta molecule can stop development of allergic reaction before evident symptoms, and at the same time they do not suppress immunity. These drugs can be made as capsules or inhalers, and not just in injections.
Fatal error: Call to undefined function related_posts() in /home/jesusbox44/medical-portal.org/wp-content/themes/medical1.0/index.php on line 81